01Purpose and principlesWhat the assessment is for and the core concepts behind it.
Troponin interpretation is a three-part task: establish whether injury exists, decide whether it is acute, then decide whether acute ischaemia is present. The final diagnosis must name the mechanism where possible.
Absolute values, delta change, symptom timing and ECG all matter. Reporting a number without the assay, reference limit and collection time invites error.
A rule-out algorithm only addresses myocardial infarction within its validated population; it does not exclude unstable angina, pulmonary embolism, aortic disease, myocarditis or another dangerous cause of pain.
Key points
- Cardiac troponin above the assay's 99th-centile upper reference limit defines myocardial injury, not its cause.
- Acute injury requires a rise or fall; myocardial infarction additionally requires clinical evidence of acute ischaemia.
- Use the validated sampling times and thresholds for the exact high-sensitivity assay in your laboratory.
- A very early low result may not exclude infarction when symptoms began recently; repeat sampling is time- and assay-dependent.
- Chronic kidney disease, heart failure and structural heart disease commonly produce persistent elevation, but acute coronary syndrome must still be assessed.
- Type 2 myocardial infarction requires ischaemia from supply-demand imbalance; non-ischaemic acute injury is not type 2 MI.
- CK-MB and myoglobin should not replace high-sensitivity cardiac troponin for routine ACS diagnosis.
02Indications, selection and cautionsWhen it is useful, when urgency changes and important limitations.
Persistent diagnostic ST elevation with a compatible presentation is a reperfusion diagnosis; troponin delay can cost myocardium.
At least one value above the 99th centile with a significant rise or fall; assay precision and the clinical interval determine whether the delta is meaningful.
Acute troponin change plus evidence of ischaemia from acute coronary atherothrombosis, such as symptoms, new ischaemic ECG change, imaging loss of viable myocardium or coronary thrombus.
Acute injury with ischaemia during a stressor such as severe anaemia, hypoxaemia, rapid tachyarrhythmia or shock, without acute atherothrombosis.
Myocarditis, pulmonary embolism, sepsis, heart failure, renal disease and cardiac procedures can elevate troponin; manage the underlying diagnosis rather than labelling every elevation NSTEMI.
03Method and interpretationA systematic approach to the test and its findings.
Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.
- 01
Serial high-sensitivity cardiac troponinFirst step - Why
- Detect or exclude acute myocardial injury.
- Interpretation and limitations
- Apply only the manufacturer's assay-specific thresholds and a locally validated NICE-supported early rule-out pathway; record symptom onset and sample times.
- 02
Serial 12-lead ECG - Why
- Identify dynamic ischaemia or an alternative rhythm diagnosis.
- Interpretation and limitations
- Repeat during pain or deterioration; troponin cannot compensate for an evolving ECG.
- 03
Renal function and full blood count - Why
- Identify chronic elevation context, anaemia, bleeding and treatment modifiers.
- Interpretation and limitations
- Renal dysfunction reduces specificity for type 1 MI but does not make a dynamic elevation benign.
- 04
Transthoracic echocardiography - Why
- Look for regional wall-motion abnormality, global dysfunction, valve disease or alternative pathology.
- Interpretation and limitations
- A new regional abnormality supports ischaemia but may be absent early; prior infarction can produce chronic abnormalities.
- 05
Targeted alternative-diagnosis testing - Why
- Investigate pulmonary embolism, myocarditis, sepsis, aortic disease or other suspected causes.
- Interpretation and limitations
- Choose testing from clinical probability; an elevated troponin should sharpen, not narrow, the differential.
04Clinical next stepsHow the result changes management or prompts escalation.
01Preferred routeSuspected NSTE-ACSFirst stepPreferredCompatible symptoms without diagnostic persistent ST elevation+
- 1Obtain ECG and first high-sensitivity troponin promptly, documenting symptom-onset time.
- 2Apply the exact assay's validated early rule-out or serial algorithm; repeat ECG and troponin if indicated.
- 3If acute injury and ischaemia coexist, diagnose MI and risk-stratify for invasive management.
- 4If ruled out, reassess the full differential and clinical risk before discharge.
02AlternativeElevated troponin without clear ACSAlternativeTroponin exceeds the 99th centile but symptoms or ECG are non-diagnostic+
- 1Compare serial values and prior baseline to distinguish acute from chronic injury.
- 2Search systematically for ischaemia, tachyarrhythmia, heart failure, pulmonary embolism, myocarditis, sepsis, hypoxaemia, anaemia and renal disease.
- 3Use echo or other imaging when it will distinguish mechanisms.
- 4Document 'acute myocardial injury', 'chronic myocardial injury' or the supported MI subtype rather than defaulting to NSTEMI.
03EscalationDiscordant or ongoing-risk presentationEscalationPersistent symptoms, dynamic ECG change or high clinical concern despite an initial low result+
- 1Continue monitored assessment and repeat ECG during symptoms.
- 2Repeat troponin at the validated later time point, especially after very early presentation.
- 3AlternativeSeek senior cardiology input and investigate alternative emergencies.
- 4Do not discharge solely from a single biomarker result outside its validated rule-out conditions.
05Risks, monitoring and follow-upComplications, safety checks and further assessment.
- Track troponin values with assay name, upper reference limit and exact collection times.
- Repeat ECG and observations with recurrent pain or deterioration.
- Monitor renal function, haemoglobin and bleeding risk before antithrombotic or contrast exposure.
- Review the documented final mechanism and avoid carrying an unsupported MI code forward.
- Arrange follow-up for unexplained persistent myocardial injury or structural disease.
06Special situationsVariants, exceptions and circumstances that change the usual approach.
Injury is not infarction
The word infarction requires acute myocardial injury plus evidence of acute ischaemia.
Delta is assay-specific
Do not transplant absolute or percentage-change criteria between assays or institutions.
Sex-specific reference limits
Some assays use sex-specific 99th centiles; use the threshold implemented and validated by the laboratory.
Late presenters may have little delta
Troponin may already be near its plateau, so history, ECG and imaging remain decisive.
Unstable angina still exists
Ischaemic symptoms without myocardial necrosis can occur, although high-sensitivity assays have reduced its frequency.
07Common pitfallsFrequent interpretation and management errors.
- 01
Calling any positive troponin an NSTEMI.
- 02
Using one universal numerical cut-off across different assays.
- 03
Letting a first negative result delay reperfusion in STEMI.
- 04
Ignoring symptom-onset time when applying an early rule-out pathway.
- 05
Discharging after MI rule-out without considering another dangerous cause of symptoms.